Waning of SARS-CoV-2 IgG antibodies after vaccination: first results from the CoMoLo follow-up 2021: Cânâ Kußmaul

BACKGROUND: In 2020, the study “Corona-Monitoring Lokal” (CoMoLo) assessed seroprevalences of SARS-CoV-2 IgG antibodies in four study locations that were particularly affected by outbreaks in the early stages of the pandemic in Germany. One of the objectives of the 2021 follow-up was to examine the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kußmaul, C, Schaffrath Rosario, A, Allen, J, Lange, M, Koschollek, C, Haller, S, Schlaud, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Parallel Programme
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593459/
http://dx.doi.org/10.1093/eurpub/ckac129.048

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9593459/
http://dx.doi.org/10.1093/eurpub/ckac129.048

Ejemplares similares